Pettinga Financial Advisors’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
Other funds holding XFOR
Pettinga Financial Advisors's XFOR Position: Q3 2026 in Review
Pettinga Financial Advisors held its X4 Pharmaceuticals (XFOR) position steady in Q3 2026 at 10,000 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #158.
Pettinga Financial Advisors first reported a position in XFOR in Q2 2026 and has held it in 2 quarters since. The position peaked at $46.7K in Q2 2026. 3 funds tracked by Wall St. Rank hold XFOR as of Q3 2026.
- Pettinga Financial Advisors held 10,000 shares of X4 Pharmaceuticals worth $29K as of Q3 2026.
- Pettinga Financial Advisors left its X4 Pharmaceuticals share count unchanged in Q3 2026.
- X4 Pharmaceuticals made up ﹤0.01% of Pettinga Financial Advisors's portfolio in Q3 2026, its #158 holding.
- Pettinga Financial Advisors first reported a position in X4 Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
- Pettinga Financial Advisors's X4 Pharmaceuticals position peaked at $46.7K in Q2 2026.
- 3 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2026.
Based on Pettinga Financial Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.